Immunoinformatics-based design of a next generation multi-epitope vaccine candidate against Shigella boydii using a hierarchical subtractive proteomics approach

1. Brown, J. D. et al. Shigella species epidemiology and antimicrobial susceptibility: the implications of emerging Azithromycin resistance for guiding treatment, guidelines and breakpoints. J. Antimicrob. Chemother. 72, 3181–3186 (2017).

   Google Scholar 

2. Hmar, E. B. L., Paul, S. & Sharma, H. K. The role of Shigella spp. In propagating bacillary dysentery In humans and the prominence of nanotechnology In disease prevention. Futur J. Pharm. Sci. 10, 97 (2024).

   Google Scholar 

3. Ranjbar, R., Farahani, A. & Shigella Antibiotic-Resistance Mechanisms And New Horizons For Treatment. IDR Volume 12, 3137–3167 (2019).

4. Afrad, M. H. et al. Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014–2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases. Microbiol. Spectr. 12, e00739–e00724 (2024).

   Google Scholar 

5. Baharvand, A. et al. The increasing antimicrobial resistance of Shigella species among Iranian pediatrics: a systematic review and meta-analysis. Pathogens Global Health. 117, 611–622 (2023).

   Google Scholar 

6. Martinez-Becerra, F. J. et al. Broadly protective Shigella vaccine based on type III secretion apparatus proteins. Infect. Immun. 80, 1222–1231 (2012).

   Google Scholar 

7. Schroeder, G. N. & Hilbi, H. Molecular pathogenesis of Shigella spp.: controlling host cell Signaling, Invasion, and death by type III secretion. Clin. Microbiol. Rev. 21, 134–156 (2008).

   Google Scholar 

8. Yang, S. C., Hung, C. F., Aljuffali, I. A. & Fang, J. Y. The roles of the virulence factor IpaB In Shigella spp. In the escape from immune cells and Invasion of epithelial cells. Microbiol. Res. 181, 43–51 (2015).

   Google Scholar 

9. Sandlin, R. C. et al. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect. Immun. 63, 229–237 (1995).

   Google Scholar 

10. Mattock, E. & Blocker, A. J. How do the virulence factors of Shigella work together to cause disease? Front Cell. Infect. Microbiol 7, (2017).

11. Qasim, M., Wrage, M., Nüse, B. & Mattner, J. Shigella outer membrane vesicles as promising targets for vaccination. IJMS 23, 994 (2022).

    Google Scholar 

12. Lu, T., Das, S., Howlader, D. R., Picking, W. D. & Picking, W. L. Shigella vaccines: the continuing unmet challenge. IJMS 25, 4329 (2024).

    Google Scholar 

13. Dingding, H. et al. Subtractive proteomics and reverse-vaccinology approaches for novel drug targets and designing a chimeric vaccine against Ruminococcus gnavus strain RJX1120. Front. Immunol. 16, 1555741 (2025).

    Google Scholar 

14. Ghaffar, S. A. et al. Designing of a multi-epitopes based vaccine against haemophilius parainfluenzae and its validation through integrated computational approaches. Front. Immunol. 15, 1380732 (2024).

    Google Scholar 

15. Rahman, S. et al. Subtractive Proteomics and Reverse-Vaccinology Approaches for Novel Drug Target Identification and Chimeric Vaccine Development against Bartonella henselae Strain Houston-1. Bioengineering 11, 505 (2024).

16. Khan, A., Khanzada, M. H., Khan, K., Jalal, K. & Uddin, R. Integrating core subtractive proteomics and reverse vaccinology for multi-epitope vaccine design against rickettsia prowazekii endemic typhus. Immunol. Res. 72, 82–95 (2024).

    Google Scholar 

17. Kar, T. et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci. Rep. 10, 10895 (2020).

    Google Scholar 

18. Mamun, T. I. et al. Designing a multi-epitope vaccine candidate against human rhinovirus C utilizing immunoinformatics approach. Front. Immunol. 15, 1364129 (2025).

    Google Scholar 

19. Ross, S. H. & Cantrell, D. A. Signaling and function of Interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411–433 (2018).

    Google Scholar 

20. Aiman, S. et al. Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella sonnei: immunoinformatics and chemoinformatics approaches. PLoS ONE. 18, e0289773 (2023).

    Google Scholar 

21. Salam, M. A. et al. Antimicrobial resistance: A growing serious threat for global public health. Healthcare 11, 1946 (2023).

    Google Scholar 

22. Basmenj, E. R. et al. Computational epitope-based vaccine design with bioinformatics approach; a review. Heliyon 11, e41714 (2025).

    Google Scholar 

23. The UniProt Consortium. The universal protein resource (UniProt). Nucleic Acids Res. 36, D190–D195 (2007).

    Google Scholar 

24. The UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204–D212 (2015).

    Google Scholar 

25. Wei, W., Ning, L. W., Ye, Y. N., Guo, F. B. & Geptop A gene essentiality prediction tool for sequenced bacterial genomes based on orthology and phylogeny. PLoS ONE. 8, e72343 (2013).

    Google Scholar 

26. Wen, Q. F. et al. Geptop 2.0: an Updated, more Precise, and faster Geptop server for identification of prokaryotic essential genes. Front. Microbiol. 10, 1236 (2019).

    Google Scholar 

27. McGinnis, S. & Madden, T. L. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 32, W20–W25 (2004).

    Google Scholar 

28. Pertsemlidis, A. & Fondon, J. W. Having a BLAST with bioinformatics (and avoiding BLASTphemy). Genome Biol 2, reviews1 (2001). (2002).

29. Gardy, J. L. PSORT-B: improving protein subcellular localization prediction for Gram-negative bacteria. Nucleic Acids Res. 31, 3613–3617 (2003).

    Google Scholar 

30. Yu, N. Y. et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608–1615 (2010).

    Google Scholar 

31. Grund, M. E., Soo, J., Cote, C. K., Berisio, R. & Lukomski, S. Thinking outside the bug: targeting outer membrane proteins for burkholderia vaccines. Cells 10, 495 (2021).

    Google Scholar 

32. Zahid, A., Ismail, H., Wilson, J. C. & Grice, I. D. Bioengineering Outer-Membrane vesicles for vaccine development: Strategies, Advances, and perspectives. Vaccines 13, 767 (2025).

    Google Scholar 

33. Tabibpour, N. S., Doosti, A. & Sharifzadeh, A. Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by immunoinformatic approaches to control acinetobacter baumannii. BMC Immunol. 24, 46 (2023).

    Google Scholar 

34. Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).

    Google Scholar 

35. Ong, E. et al. Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning. Nucleic Acids Res. 49, W671–W678 (2021).

    Google Scholar 

36. Bevacqua, A., Bakshi, S. & Xia, Y. Principal component analysis of alpha-helix deformations in transmembrane proteins. PLoS ONE. 16, e0257318 (2021).

    Google Scholar 

37. Bianchi, F., Textor, J. & Van Den Bogaart, G. Transmembrane helices are an overlooked source of major histocompatibility complex class I epitopes. Front. Immunol. 8, 1118 (2017).

    Google Scholar 

38. De Araújo, L. P., Silva, E. N., De Alencar, S. M. & Corsetti, P. P. De Almeida, L. A. Multivalent vaccine candidate from conserved Immunogenic peptides in entry or exit proteins of orthopoxvirus genus. Sci. Rep. 15, 12503 (2025).

    Google Scholar 

39. Hewitt, E. W. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110, 163–169 (2003).

    Google Scholar 

40. Wieczorek, M. et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol 8, (2017).

41. Waqas, M. et al. Immunoinformatics design of multivalent epitope vaccine against Monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Front. Immunol. 14, 1091941 (2023).

    Google Scholar 

42. Lundegaard, C., Lund, O., Buus, S. & Nielsen, M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130, 309–318 (2010).

    Google Scholar 

43. Vilela Rodrigues, T. C. et al. An immunoinformatics-based designed multi-epitope candidate vaccine (mpme-VAC/STV-1) against Mycoplasma pneumoniae. Comput. Biol. Med. 142, 105194 (2022).

    Google Scholar 

44. Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2—a server for in Silico prediction of allergens. J. Mol. Model. 20, 2278 (2014).

    Google Scholar 

45. Rezaei, M., Habibi, M., Ehsani, P., Asadi Karam, M. R. & Bouzari, S. Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections. Bioimpacts 14, 27513 (2023).

    Google Scholar 

46. Roohparvar Basmenj, E., Omidvar, B., Kiumarsy, A., Izadkhah, H. & Ghiabi, S. Design of a multi-epitope-based peptide vaccine against the SARS-CoV-2 Omicron variant using bioinformatics approach. J. Biomol. Struct. Dynamics. 42, 7945–7956 (2024).

    Google Scholar 

47. Gomes, L. G. R. et al. In Silico designed Multi-Epitope immunogen Tpme-VAC/LGCM-2022 May induce both cellular and humoral immunity against Treponema pallidum infection. Vaccines 10, 1019 (2022).

    Google Scholar 

48. Wang, P. et al. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4, e1000048 (2008).

    Google Scholar 

49. Maleki, A., Russo, G., Parasiliti Palumbo, G. A. & Pappalardo, F. In Silico design of Recombinant multi-epitope vaccine against influenza A virus. BMC Bioinform. 22, 617 (2022).

    Google Scholar 

50. EL-Manzalawy, Y., Dobbs, D. & Honavar, V. Predicting linear B‐cell epitopes using string kernels. J. Mol. Recognit. 21, 243–255 (2008).

    Google Scholar 

51. Srivastava, K. & Srivastava, V. Prediction of conformational and linear B-Cell epitopes on envelop protein of Zika virus using immunoinformatics approach. Int. J. Pept. Res. Ther. 29, 17 (2023).

    Google Scholar 

52. Liu, F., Yuan, C., Chen, H. & Yang, F. Prediction of linear B-cell epitopes based on protein sequence features and BERT embeddings. Sci. Rep. 14, 2464 (2024).

    Google Scholar 

53. Sarkar, B., Ullah, M. A., Johora, F. T., Taniya, M. A. & Araf, Y. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Immunobiology 225, 151955 (2020).

    Google Scholar 

54. Jamali, S., Zamanzadeh, Z., Asadzadeh, A., Owji, F. & Abkar, M. Design of a multi-epitope vaccine using HA and M1 proteins from influenza and S, E, and M proteins from SARS-CoV-2 by in Silico tools. Inf. Med. Unlocked. 43, 101397 (2023).

    Google Scholar 

55. Stratmann, T. Cholera toxin subunit B as Adjuvant––An accelerator in protective immunity and a break in autoimmunity. Vaccines 3, 579–596 (2015).

    Google Scholar 

56. Shamriz, S., Ofoghi, H. & Moazami, N. Effect of linker length and residues on the structure and stability of a fusion protein with malaria vaccine application. Comput. Biol. Med. 76, 24–29 (2016).

    Google Scholar 

57. Sanchez, A. E., Aquino, G., Ostoa-Saloma, P. & Laclette, J. P. Rocha-Zavaleta, L. Cholera toxin B-Subunit gene enhances mucosal Immunoglobulin A, Th1-Type, and CD8⁺ cytotoxic responses when coadministered intradermally with a DNA vaccine. Clin. Vaccine Immunol. 11, 711–719 (2004).

    Google Scholar 

58. Liljeroos, L., Malito, E., Ferlenghi, I. & Bottomley, M. J. Structural and computational biology in the design of Immunogenic vaccine antigens. J. Immunol. Res. 2015, 1–17 (2015).

    Google Scholar 

59. Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 7, 153 (2006).

    Google Scholar 

60. Nguyen, T. L. & Kim, H. Discovering peptides and computational investigations of a multiepitope vaccine target Mycobacterium tuberculosis. Synth. Syst. Biotechnol. 9, 391–405 (2024).

    Google Scholar 

61. Department of Computational Biology & & Bioinformatics Jacob school of biotechnology & Bioengineering, Sam Higginbottom Institute of agriculture technology & Sciences, Allahabad-211007, Uttar Pradesh, Bharat (India). MFPPI – Multi FASTA ProtParam Interface. Bioinformation. 12, 74–77 (2016).

    Google Scholar 

62. Geourjon, C. & Deléage, G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11, 681–684 (1995).

    Google Scholar 

63. Bertoline, L. M. F., Lima, A. N., Krieger, J. E. & Teixeira, S. K. Before and after AlphaFold2: an overview of protein structure prediction. Front. Bioinform. 3, 1120370 (2023).

    Google Scholar 

64. Heo, L., Park, H. & Seok, C. GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41, W384–W388 (2013).

    Google Scholar 

65. Wang, W. et al. Data set for phylogenetic tree and RAMPAGE Ramachandran plot analysis of SODs in Gossypium raimondii and G. arboreum. Data Brief. 9, 345–348 (2016).

    Google Scholar 

66. Binbay, F. A., Rathod, D. C., George, A. A. P. & Imhof, D. Quality assessment of selected protein structures derived from homology modeling and alphafold. Pharmaceuticals 16, 1662 (2023).

    Google Scholar 

67. Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. 9, 514 (2008).

    Google Scholar 

68. Tahir, U. et al. Multiepitope-Based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach. Vaccines 8, 288 (2020).

    Google Scholar 

69. Tahir, U. et al. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: immunoinformatics and in Silico approaches. PLoS ONE. 15, e0244176 (2020).

    Google Scholar 

70. Maeshima, N. & Fernandez, R. C. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell. Inf. Microbio 3, (2013).

71. Ain, Q. U., Batool, M. & Choi, S. TLR4-Targeting therapeutics: structural basis and Computer-Aided drug discovery approaches. Molecules 25, 627 (2020).

    Google Scholar 

72. Kozakov, D. et al. The cluspro web server for protein–protein Docking. Nat. Protoc. 12, 255–278 (2017).

    Google Scholar 

73. Raj, K. H. et al. A robust comprehensive immunoinformatics approach for designing a potential multi-epitope based vaccine against a reiterated Monkeypox virus. Biochem. Biophys. Rep. 43, 102075 (2025).

    Google Scholar 

74. Schmit, J. D., Kariyawasam, N. L., Needham, V. & Smith, P. E. SLTCAP: A simple method for calculating the number of ions needed for MD simulation. J. Chem. Theory Comput. 14, 1823–1827 (2018).

    Google Scholar 

75. Abraham, M. J. & Gready, J. E. Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J. Comput. Chem. 32, 2031–2040 (2011).

    Google Scholar 

76. Quezada, G. R. et al. Molecular Dynamics Study of Polyacrylamide and Polysaccharide-Derived Flocculants Adsorption on Mg(OH)2 Surfaces at pH 11. Polymers 17, 227 (2025).

77. Childers, M. C. & Daggett, V. Validating molecular dynamics simulations against experimental observables in light of underlying conformational ensembles. J. Phys. Chem. B. 122, 6673–6689 (2018).

    Google Scholar 

78. Hunt-Isaak, I., Russell, J. & Hekstra, D. mpl-interactions: A python package for interactivematplotlib figures. JOSS 9, 5651 (2024).

    Google Scholar 

79. Shakibay Senobari, Z. et al. Chromone-embedded peptidomimetics and furopyrimidines as highly potent SARS-CoV-2 infection inhibitors: Docking and MD simulation study. BMC Res. Notes. 16, 224 (2023).

    Google Scholar 

80. Elshafei, S. O., Mahmoud, N. A. & Almofti, Y. A. Immunoinformatics, molecular Docking and dynamics simulation approaches unveil a multi epitope-based potent peptide vaccine candidate against avian leukosis virus. Sci. Rep. 14, 2870 (2024).

    Google Scholar 

81. López-Blanco, J. R., Aliaga, J. I., Quintana-Ortí, E. S. & Chacón, P. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 42, W271–W276 (2014).

    Google Scholar 

82. Ma, J. Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13, 373–380 (2005).

    Google Scholar 

83. Singh, K. V. Eigenvalue and eigenvector computation for discrete and continuous structures composed of viscoelastic materials. Int. J. Mech. Sci. 110, 127–137 (2016).

    Google Scholar 

84. Yu, C. C., Raj, N. & Chu, J. W. Statistical learning of protein elastic network from positional covariance matrix. Comput. Struct. Biotechnol. J. 21, 2524–2535 (2023).

    Google Scholar 

85. Ashgar, S. S. et al. Integrated immunoinformatics and subtractive proteomics approach for multi-epitope vaccine designing to combat S. pneumoniae TIGR4. Front. Mol. Biosci. 10, 1212119 (2023).

    Google Scholar 

86. Kumar, K. M. et al. Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2. Front. Microbiol. 14, 1251716 (2023).

    Google Scholar 

87. Bergström, T. F., Josefsson, A., Erlich, H. A. & Gyllensten, U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat. Genet. 18, 237–242 (1998).

    Google Scholar 

88. Russo, G. et al. In Silico trial to test COVID-19 candidate vaccines: a case study with UISS platform. BMC Bioinform. 21, 527 (2020).

    Google Scholar 

89. Grote, A. et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33, W526–W531 (2005).

    Google Scholar 

90. Parvathy, S. T., Udayasuriyan, V. & Bhadana, V. Codon usage bias. Mol. Biol. Rep. 49, 539–565 (2022).

    Google Scholar 

91. Paremskaia, A. I. et al. Codon-optimization in gene therapy: promises, prospects and challenges. Front. Bioeng. Biotechnol. 12, 1371596 (2024).

    Google Scholar 

92. Kelpšas, V. & Wachenfeldt, C. V. Strain improvement of Escherichia coli K-12 for Recombinant production of deuterated proteins. Sci. Rep. 9, 17694 (2019).

    Google Scholar 

93. Chick, J. A., Abongdia, N. N., Shey, R. A. & Apinjoh, T. O. Computational design, expression, and characterization of a Plasmodium falciparum multi-epitope, multi-stage vaccine candidate (PfCTMAG). Heliyon 11, e42014 (2025).

94. Niyogi, S. K. & Shigellosis J. Microbiol. 43, 133–143 (2005).

    Google Scholar 

95. Zaidi, M. B., Estrada-García, T. & Shigella A highly virulent and elusive pathogen. Curr. Trop. Med. Rep. https://doi.org/10.1007/s40475-014-0019-6 (2014).

    Google Scholar 

96. Botos, I. et al. Structural and functional characterization of the LPS transporter LptDE from Gram-Negative pathogens. Structure 24, 965–976 (2016).

    Google Scholar 

97. Bisson-Filho, A. W. et al. Treadmilling by FtsZ filaments drives peptidoglycan synthesis and bacterial cell division. Science 355, 739–743 (2017).

    Google Scholar 

98. Hou, J. et al. Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice. Hum. Vaccines Immunotherapeutics. 10, 1274–1283 (2014).

    Google Scholar 

99. Srinivasan, S. et al. Epitope identification and designing a potent multi-epitope vaccine construct against SARS-CoV-2 including the emerging variants. J. Global Infect. Dis. 14, 24 (2022).

    Google Scholar 

100. Khan, M. T. et al. Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2. Inf. Med. Unlocked. 24, 100578 (2021).

     Google Scholar 

101. Shang, K. et al. Development of a novel multi-epitope vaccine for brucellosis prevention. Heliyon 10, e34721 (2024).

     Google Scholar 

102. Tan, C. et al. Immunoinformatics approach toward the introduction of a novel Multi-Epitope vaccine against clostridium difficile. Front. Immunol. 13, 887061 (2022).

     Google Scholar 

103. Woelke, A. L. et al. Development of Immune-Specific interaction potentials and their application in the Multi-Agent-System vaccimm. PLoS ONE. 6, e23257 (2011).

     Google Scholar 

104. Mahmoodi, S., Amirzakaria, J. Z. & Ghasemian, A. In Silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses. PLoS ONE. 18, e0285177 (2023).

     Google Scholar 

105. Qureshi, H. et al. Designing a multi-epitope vaccine against Shigella dysenteriae using immuno-informatics approach. Front. Genet. 15, 1361610 (2024).

     Google Scholar 

106. Farhani, I., Nezafat, N. & Mahmoodi, S. Designing a novel Multi-epitope peptide vaccine against pathogenic Shigella spp. Based immunoinformatics approaches. Int. J. Pept. Res. Ther. 25, 541–553 (2019).

     Google Scholar 

107. Hashemi, P. et al. A multi-epitope protein vaccine encapsulated in alginate nanoparticles as a candidate vaccine against Shigella sonnei. Sci. Rep. 14, 22484 (2024).

     Google Scholar 

108. Jalal, K. et al. Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach. Sci. Rep. 12, 251 (2022).

     Google Scholar 

109. Raso, M. M., Arato, V., Gasperini, G. & Micoli, F. Toward a Shigella vaccine: opportunities and challenges to fight an Antimicrobial-Resistant pathogen. IJMS 24, 4649 (2023).

     Google Scholar 

110. Martić-Kehl, M. I., Schibli, R. & Schubiger, P. A. Can animal data predict human outcome? Problems and pitfalls of translational animal research. Eur. J. Nucl. Med. Mol. Imaging. 39, 1492–1496 (2012).

     Google Scholar 

111. Ullah, H., Mahmud, S., Hossain, M. J., Islam, M. S. B. & Kibria, K. M. K. Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular Docking confirmation. Infect. Genet. Evol. 96, 105129 (2021).

     Google Scholar 

Download references